SAN FRANCISCO, Jan. 12, 2023 /PRNewswire/ -- The global healthcare consulting services market size is expected to reach USD 25.9 billion by 2030 and register a CAGR of 8.3% from 2023 to 2030, according to a new report by Grand View Research, Inc. The increasing budget cuts, the desire to enhance operational efficiency, changing healthcare policies and regulations, and growing demand to implement new technologies such as big data analytics, cloud deployment, and IoT among healthcare institutions such as life sciences companies and government bodies are some of the key factors driving the healthcare consulting services market.
Key Industry Insights & Findings from the report:
- Based on services the strategic management segment held the largest share of 49.0% in 2022 owing to the growing demand for M&A strategy consulting among the healthcare organizations.
- Based on end-use, the pharmaceutical companies segment accounted for a maximum share of 27.9% in 2022. The growing need to manage costs associated with various operations in the pharmaceutical company and the increasing demand for brand management of existing products are supporting segment growth.
- Based on region, North America dominated the market in 2022 and accounted for a share of 47.3% due to the increase in the adoption of digitalization among healthcare organizations.
Read 100 page market research report, "Healthcare Consulting Services Market Size, Share & Trends Analysis Report By Services (Strategic Management Consulting), By End-use (Hospitals), By Region, And Segment Forecasts, 2023 - 2030", published by Grand View Research.
Healthcare Consulting Services Market Growth & Trends
Healthcare consulting services firms assist healthcare organizations in increasing their efficiency and profits; they also assist in providing structural recommendations for the firm. These advantages associated with healthcare consulting are expected to improve demand for these services across the forecast period. Over the years, there has been uncertainty over healthcare reform, growth in employer self-insurance, a rise in patient pay responsibility, and a growing demand for understanding healthcare coverage. These issues are likely to improve the demand for healthcare consulting services for managing payers' needs.
Pharmaceutical companies are heavily investing in the research and development of new drugs. As a result, the number of new drugs in the pipeline has increased in recent years. According to the Pharma R&D annual review, as of 2022, over 20,109 drugs were in the pipeline. These drugs are expected to be launched in the coming years. Due to the uncertainties created by the COVID-19 pandemic, pharmaceutical companies are expected to collaborate with strategic consultants to develop their launch strategy. This is expected to support market growth in the post-pandemic period.
Healthcare Consulting Services Market Segmentation
Grand View Research has segmented the global healthcare consulting services market report based on services, end-use, and region.
Healthcare Consulting Services Market - Outlook (Revenue, USD Million, 2018 - 2030)
- Strategic Management Consulting
- Financial Management Consulting
- Information Technology Consulting
- Human Resource Consulting
- Others
Healthcare Consulting Services Market - End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Pharmaceutical Companies
- Hospitals
- Insurance Companies
- Government Organizations
- Other Healthcare Providers
Healthcare Consulting Services Market - Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- China
- India
- Japan
- Australia
- Thailand
- South Korea
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
List of Key Players in Healthcare Consulting Services Market
- Accenture
- McKinsey & Company
- Deloitte
- PwC
- L.E.K. Consulting
- Huron Consulting Group Inc.
- Cognizant
- EY
- Bain & Company, Inc.
- IQVIA, Inc.
- Boston Consulting Group
Check out more related studies published by Grand View Research:
- Biotechnology & Pharmaceutical Services Outsourcing Market - The global biotechnology and pharmaceutical services outsourcing market size is expected to reach USD 108.0 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.5% from 2022 to 2030. The COVID-19 pandemic has significantly impacted Biotechnology and Pharmaceutical third-party service providers as well as clinical trials, resulting in trial delay, suspensions, and terminations. The global crisis has stressed the need for virtual trials and leveraging technology and software solutions. The recovery from the pandemic has led to increasing adoption of machine learning-based platforms, artificial intelligence, automation in drug manufacturing, and innovative trial designs are projected to transform the CRO and CMO landscape in the coming years.
- Weight Loss Services Market - The global weight loss services market size is expected to reach USD 21.1 billion by 2025 expanding at a CAGR of 8.4%, according to a new report by Grand View Research, Inc. Rising cases of obesity and resultant health consciousness along with increased per capita healthcare expenditure are the key factors fueling the market growth. Obesity is among the major health concerns that lead to a number of associated diseases or complications, such as diabetes, Cardiovascular Diseases (CVDs), and cancers. For instance, as per WHO, in 2016, more than 1.9 billion adults were overweight, out of which around 650 million people were obese.
- Clinical Trial Management Services Market - The global clinical trial management services market size is anticipated to reach USD 52.1 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.5% from 2022 to 2030. The increasing trend of outsourcing clinical trial activities, the rise in research and development of advanced therapies, and the globalization of clinical trials are a few key factors driving the growth of the market.
Browse through Grand View Research's Medical Devices Industry Research Reports.
About Grand View Research
Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: +1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: https://www.grandviewresearch.com
Grand View Compass | Astra ESG Solutions
Follow Us: LinkedIn | Twitter
Logo: https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg

Share this article